Steven Rosenberg
Tracked across 1 events · 8 articles · First seen Jun 16, 2026 · Last active Jun 16, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Dr. Steven Rosenberg is recognized as a joint laureate of the Tang Prize in Biopharmaceutical Science for his pioneering work in tumor-infiltrating lymphocyte (TIL) therapy and foundational clinical framework for adoptive cell therapy (ACT).
Jun 16, 2026 · 8 articles
ERGEN INTELLIGENCE
Track Steven Rosenberg live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard